 LEIDEN, Netherlands CAMBRIDGE, Mass., Aug. 11, 2021 GLOBE NEWSWIRE -- ProQR Therapeutics N.V. Nasdaq: PRQR the Company, a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present at the upcoming HC Wainwright Ophthalmology Virtual Conference. The presentation will be available on demand on August 17, 2021, at 7:00 am EDT. 